New York Life Investment Management’s GoodRx Holdings GDRX Stock Holding History

New York Life Investment Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,686	Closed	-$373K	–	1407
2023 Q4	$373K	Sell	55,686 -1,281	-2%	-$7.21K	﹤0.01%	1054
2023 Q3	$321K	Sell	56,967 -8,974	-14%	-$59.8K	﹤0.01%	1090
2023 Q2	$364K	Sell	65,941 -12,534	-16%	-$67.5K	﹤0.01%	1126
2023 Q1	$490K	Buy	+78,475	New	+$437K	0.01%	725

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

New York Life Investment Management's GDRX Position: Q1 2024 in Review

New York Life Investment Management sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 55,686 shares — an estimated $373K sold.

New York Life Investment Management first reported a position in GDRX in Q1 2023 and held it in 4 quarters. The position peaked at $490K in Q1 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

New York Life Investment Management reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
New York Life Investment Management sold 55,686 GoodRx Holdings shares in Q1 2024, an estimated $373K.
New York Life Investment Management first reported a position in GoodRx Holdings in Q1 2023 and held it in 4 quarters.
New York Life Investment Management's GoodRx Holdings position peaked at $490K in Q1 2023.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.